STAMPEDE: Bariatric surgery gains more evidence based support

Area of Science:

• Metabolic disorders
• Surgical interventions
• Clinical research

Background:

• Diabetes mellitus (DM) and obesity contribute significantly to morbidity and mortality.
• Intensive medical management trials for obesity and diabetes have yielded disappointing results.
• Bariatric surgery shows promise for managing DM in observational and small-scale studies.

Purpose of the Study:

• To evaluate the long-term efficacy of sleeve gastrectomy and gastric bypass versus intensive medical management.
• To assess the impact of bariatric surgery on patients with both type 2 diabetes and obesity.
• To provide data from a larger cohort in the STAMPEDE trial over a 3-year follow-up.

Main Methods:

• The STAMPEDE trial compared sleeve gastrectomy and gastric bypass to intensive medical therapy.
• The study included a larger cohort of patients diagnosed with DM and obesity.
• Follow-up was conducted over a 3-year period.

Main Results:

• Bariatric surgery interventions (sleeve gastrectomy and gastric bypass) demonstrated superior outcomes.
• Significant improvements were observed in patients with type 2 diabetes and obesity.
• The 3-year follow-up confirmed the sustained benefits of surgical approaches.

Conclusions:

• Sleeve gastrectomy and gastric bypass are effective treatments for type 2 diabetes and obesity.
• Bariatric surgery offers a more effective alternative to medical management for select patients.
• The STAMPEDE trial provides robust evidence supporting surgical intervention for metabolic disease.